We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
Trades about 39% below its sector, cheaper than its peers on earnings.
Lagis Enterprise Co., Ltd. is a medical technology company focused on the development and global distribution of specialized devices for laparoscopic and endoscopic surgical procedures. Their comprehensive product portfolio includes trocars, single-port surgery systems, and wound protectors. They also offer a range of endo devices, such as precision hand instruments and advanced bipolar tools, alongside specimen retrieval products, suction-irrigation systems and pumps, surgical training solutions, and various related accessories. Founded in 1993, the company maintains its headquarters in Taichung, Taiwan.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save 6730.TWO and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
